Paving the Way for Therapy: The Second International Conference of the Trisomy 21 Research Society

Roger H. Reeves, Jean Delabar, Marie-Claude Potier, Anita Bhattacharyya, Elizabeth Head, Cynthia Lemere, Alain D. Dekker, Peter De Deyn, Pablo Caviedes, Mara Dierssen, Jorge Busciglio*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)


In the last decade, a number of important research advances in different fields have allowed Down syndrome (DS) research to flourish, creating a time of both unparalleled opportunity and considerable challenge. Building a scientific framework that distills mechanisms involved in the developmental intellectual disability of DS as well as the early-onset component of Alzheimer disease and the several other comorbidities associated with the condition is a challenge that scientists are now tackling using novel technologies and multidisciplinary approaches. The Trisomy 21 Research Society (T21RS) was founded in 2014 to address these evolving needs and challenges. In June of 2017, the T21RS held its 2nd International Conference in Chicago, USA. With more than 200 scientists, advocates, people with DS, and family members in attendance, the meeting served as a forum for the discussion of the latest research and clinical advances as well as the most compelling needs of people with DS and their families.

Original languageEnglish
Pages (from-to)279-286
Number of pages8
JournalMolecular Syndromology
Issue number6
Publication statusPublished - Jan-2019


  • Alzheimer disease
  • Down syndrome
  • Trisomy 21 Research Society

Cite this